DANA-FARBER CANCER INSTITUTE
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1947-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.dana-farber.org/
RecoverPC: Relugolix vs GnRH Agonist in Quality of Life
- Conditions
- Interventions
- First Posted Date
- 2023-03-13
- Last Posted Date
- 2024-02-14
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 110
- Registration Number
- NCT05765500
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Dana-Farber Cancer Institute at Foxborough, Foxboro, Massachusetts, United States
Enhancing Information Management for Young Adults After Genetic Cancer Risk Testing
- Conditions
- Interventions
- First Posted Date
- 2023-03-08
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 40
- Registration Number
- NCT05759143
- Locations
- 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
High-Intensity Interval Exercise in Young Adult Survivors of Pediatric Brain Tumors: A Pilot Feasibility Study
- Conditions
- Interventions
- First Posted Date
- 2023-02-23
- Last Posted Date
- 2024-02-20
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 30
- Registration Number
- NCT05740839
- Locations
- 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Pirtobrutinib and Venetoclax in Waldenström Macroglobulinemia
- Conditions
- Interventions
- First Posted Date
- 2023-02-21
- Last Posted Date
- 2024-11-08
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 42
- Registration Number
- NCT05734495
- Locations
- 🇺🇸
Beth Israel Deaconness Medical, Boston, Massachusetts, United States
🇺🇸Dana Farber Cancer Institute, Boston, Massachusetts, United States
Preoperative Pembrolizumab and Chemotherapy in Resectable, Recurrent HNSCC
- First Posted Date
- 2023-02-13
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 28
- Registration Number
- NCT05726370
- Locations
- 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Brigham and Women's Hospital, Boston, Massachusetts, United States
STOP-HER2: Stopping Trastuzumab in HER2+ MBC
- Conditions
- Interventions
- First Posted Date
- 2023-02-09
- Last Posted Date
- 2024-09-30
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 82
- Registration Number
- NCT05721248
- Locations
- 🇺🇸
Mayo Clinic Hospital Arizona, Phoenix, Arizona, United States
🇺🇸Georgetown University Medical Center, Washington, District of Columbia, United States
🇺🇸Mayo Clinical Hospital Florida, Jacksonville, Florida, United States
Patient-Centered Surgical Prehabilitation
- Conditions
- Interventions
- First Posted Date
- 2023-02-08
- Last Posted Date
- 2023-03-22
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 25
- Registration Number
- NCT05715684
- Locations
- 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Brigham and Women's Hospital, Boston, Massachusetts, United States
Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
- Conditions
- Interventions
- First Posted Date
- 2023-01-31
- Last Posted Date
- 2024-08-29
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 30
- Registration Number
- NCT05706766
- Locations
- 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Dana Farber Cancer Institute, Boston, Massachusetts, United States
A Novel Intervention for Patients With Cancer
- Conditions
- Interventions
- First Posted Date
- 2022-12-08
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 40
- Registration Number
- NCT05643027
- Locations
- 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC)
- Conditions
- Interventions
- First Posted Date
- 2022-11-29
- Last Posted Date
- 2024-10-28
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 800
- Registration Number
- NCT05629065
- Locations
- 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States